Yahoo

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

(Reuters) - Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey ...
Yahoo

Federal government to penalize AbbVie over the price of its blockbuster drug Humira

Add Yahoo as a preferred source to see more of our stories on Google. North Chicago-based drugmaker AbbVie must pay back Medicare for raising the price of its blockbuster drug Humira too quickly, the ...
FiercePharma

CVS Caremark to kick AbbVie's Humira off some formularies in favor of cheaper biosimilars

This year, CVS Health plans to employ the classic "out with the old, in with the new" mantra when it comes to AbbVie’s Humira. Come April 1, the branded drug will be replaced by cheaper biosimilars ...

AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline

By Kamal Choudhury and Christy Santhosh April 29 (Reuters) - AbbVie on Wednesday reported better-than-expected quarterly revenue and profit, fueled by demand for newer immunology drugs Skyrizi and ...
FiercePharma

AbbVie's new Rinvoq win could help soften Humira's fall in 2023

AbbVie is piling up indications on its latest drugs to help cushion Humira’s fall as the immunology cash cow inches ever closer toward its patent cliff, with biosimilar competition expected to start ...
Nasdaq

Do Humira Biosimilars Threaten AbbVie's Dividend?

Pharmaceutical giant AbbVie (NYSE: ABBV) is known for its top-selling drug Humira and its lucrative dividend that yields more than 4% at the current share price. This week Humira, which treats ...
CNBC

CVS pushes into making cheaper versions of complex drugs with new discount Humira

CVS Health is partnering with drugmaker Sandoz to produce a near identical version of the blockbuster arthritis treatment Humira. It will be priced more than 80% lower than the current list price of ...
MarketWatch

For AbbVie’s blockbuster Humira, cheaper competitors pose surprisingly little threat, analysts say

AbbVie’s ABBV rheumatoid arthritis drug Humira, one of the top-selling biopharmaceutical products of all time, will have new lower-cost competition starting Saturday. But even as nearly identical ...
Forbes

Dutch Judges To Decide Whether Humira’s Price And AbbVie’s Profits Are “Too High”

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. In a unique challenge to drug makers, the Dutch Pharmaceutical ...
Forbes

UnitedHealth’s Optum Rx To Coax Patients To Less Pricey Biosimilars Of Abbvie’s Humira

UnitedHealth Group’s pharmacy benefit manager Optum Rx Tuesday said it will put three less expensive “biosimilar” versions of Abbvie’s pricey rheumatoid arthritis drug Humira “in the same position as ...
AOL

UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year

(Reuters) - UnitedHealth Group said on Tuesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of Jan. 1, 2025, and ...